A citation-based method for searching scientific literature

Jeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, Lily R Van Tongeren, Holly LaDuca, Kathleen R Blazer, Thomas Slavin, D A B M D Facmg, Tina Pesaran, Christina Rybak, Ilana Solomon, Mariana Niell-Swiller, Jill S Dolinsky, Danielle Castillo, Aaron Elliott, Chia-Ling Gau, Virginia Speare, Kory Jasperson. Genet Med 2018
Times Cited: 57







List of co-cited articles
371 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
49

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
40

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
267
33

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
26

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
Catherine C Coombs, Ahmet Zehir, Sean M Devlin, Ashwin Kishtagari, Aijazuddin Syed, Philip Jonsson, David M Hyman, David B Solit, Mark E Robson, José Baselga,[...]. Cell Stem Cell 2017
247
24

Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel.
Bradford Coffee, Hannah C Cox, John Kidd, Scott Sizemore, Krystal Brown, Susan Manley, Debora Mancini-DiNardo. Cancer Genet 2017
28
50

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.
Elizabeth M Swisher, Maria I Harrell, Barbara M Norquist, Tom Walsh, Mark Brady, Ming Lee, Robert Hershberg, Kimberly R Kalli, Heather Lankes, Eric Q Konnick,[...]. JAMA Oncol 2016
54
24

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
22

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Christian P Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose McGee,[...]. Clin Cancer Res 2017
179
22

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome.
Mariette Renaux-Petel, Françoise Charbonnier, Jean-Christophe Théry, Pierre Fermey, Gwendoline Lienard, Jacqueline Bou, Sophie Coutant, Myriam Vezain, Edwige Kasper, Steeve Fourneaux,[...]. J Med Genet 2018
35
34

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
333
21

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
782
17

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.
Huma Q Rana, Rebecca Gelman, Holly LaDuca, Rachel McFarland, Emily Dalton, Jennifer Thompson, Virginia Speare, Jill S Dolinsky, Elizabeth C Chao, Judy E Garber. J Natl Cancer Inst 2018
36
27

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
174
17

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
913
15


High frequency of de novo mutations in Li-Fraumeni syndrome.
K D Gonzalez, C H Buzin, K A Noltner, D Gu, W Li, D Malkin, S S Sommer. J Med Genet 2009
95
15

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
15

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Shunsuke Kato, Shuang-Yin Han, Wen Liu, Kazunori Otsuka, Hiroyuki Shibata, Ryunosuke Kanamaru, Chikashi Ishioka. Proc Natl Acad Sci U S A 2003
501
15

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
223
15

Mutational processes shape the landscape of TP53 mutations in human cancer.
Andrew O Giacomelli, Xiaoping Yang, Robert E Lintner, James M McFarland, Marc Duby, Jaegil Kim, Thomas P Howard, David Y Takeda, Seav Huong Ly, Eejung Kim,[...]. Nat Genet 2018
103
15

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.
Yuebi Hu, Bryan C Ulrich, Julianna Supplee, Yanan Kuang, Patrick H Lizotte, Nora B Feeney, Nicolas M Guibert, Mark M Awad, Kwok-Kin Wong, Pasi A Jänne,[...]. Clin Cancer Res 2018
164
14

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Nancy K Gillis, Markus Ball, Qing Zhang, Zhenjun Ma, YuLong Zhao, Sean J Yoder, Maria E Balasis, Tania E Mesa, David A Sallman, Jeffrey E Lancet,[...]. Lancet Oncol 2017
128
14

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin, Monica Hollstein, Graham Byrnes, Jiri Zavadil, Magali Olivier. Hum Mutat 2016
325
14

Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Felipe Batalini, Ellie G Peacock, Lindsey Stobie, Alison Robertson, Judy Garber, Jeffrey N Weitzel, Nadine M Tung. Breast Cancer Res 2019
17
47

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
287
12

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
755
12

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.
Mandy L Ballinger, Ana Best, Phuong L Mai, Payal P Khincha, Jennifer T Loud, June A Peters, Maria Isabel Achatz, Rubens Chojniak, Alexandre Balieiro da Costa, Karina Miranda Santiago,[...]. JAMA Oncol 2017
89
12

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012
75
12

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
12

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
185
12

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003
119
12

Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, Kelly Bolton, Zarina Yelskaya, David M Hyman, David B Solit, José Baselga, Maria E Arcila, Marc Ladanyi,[...]. JAMA Oncol 2018
69
12


Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
12

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
954
12

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Terrence N Wong, Giridharan Ramsingh, Andrew L Young, Christopher A Miller, Waseem Touma, John S Welch, Tamara L Lamprecht, Dong Shen, Jasreet Hundal, Robert S Fulton,[...]. Nature 2015
389
10

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
168
10

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
68
10

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
10


Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.
Catherine C Coombs, Nancy K Gillis, Xianming Tan, Jonathan S Berg, Markus Ball, Maria E Balasis, Nathan D Montgomery, Kelly L Bolton, Joel S Parker, Tania E Mesa,[...]. Clin Cancer Res 2018
40
15

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
10

Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.
Kelvin C de Andrade, Megan N Frone, Talia Wegman-Ostrosky, Payal P Khincha, Jung Kim, Amina Amadou, Karina M Santiago, Fernanda P Fortes, Nathanaël Lemonnier, Lisa Mirabello,[...]. Hum Mutat 2019
29
20

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003
291
10

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.
Eran Kotler, Odem Shani, Guy Goldfeld, Maya Lotan-Pompan, Ohad Tarcic, Anat Gershoni, Thomas A Hopf, Debora S Marks, Moshe Oren, Eran Segal. Mol Cell 2018
58
10

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn,[...]. Breast Cancer Res Treat 2012
88
10

Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing.
Jessica L Mester, Sarah A Jackson, Kristen Postula, Amy Stettner, Sheila Solomon, Jeffrey Bissonnette, Patricia D Murphy, Rachel T Klein, Kathleen S Hruska. J Mol Diagn 2020
8
75

Mosaicism in health and disease - clones picking up speed.
Lars A Forsberg, David Gisselsson, Jan P Dumanski. Nat Rev Genet 2017
115
8

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Koichi Takahashi, Feng Wang, Hagop Kantarjian, Denaha Doss, Kanhav Khanna, Erika Thompson, Li Zhao, Keyur Patel, Sattva Neelapu, Curtis Gumbs,[...]. Lancet Oncol 2017
154
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.